Heart rate variability as a predictor of sudden cardiac death

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue SUPPL. 1, 2007, Pages 68-70

  Kudaiberdieva, Gulmira ^a,c   Görenek, Bülent ^b   Timuralp, Bilgin ^b  

^a National Center of Cardiology and Therapy   (Kyrgyzstan)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Heart failure; Heart rate variability; Myocardial infarction; Sudden cardiac death

Indexed keywords

FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART RATE VARIABILITY; HIGH RISK PATIENT; HUMAN; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; REVIEW; RISK ASSESSMENT; SUDDEN DEATH;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; PROGNOSIS;

EID: 34447109483     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Smith TW, Cain ME. Sudden cardiac death: epidemiologic and financial worldwide perspective. J Interv Card Electrophysiol 2006; 17: 199-203.
2. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2002; 22: 1374-450.
3. Goraya TY, Jacobsen SJ, Kottke TE, Frye RL, Weston SA, Roger VL. Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol 2003; 157: 763-70.
4. Al-Khatib SM, Sanders GD, Bigger JT, Buxton AE, Califf RM, Carlson M, et al; Expert panel participating in a Duke's Center for the Prevention of Sudden Cardiac Death conference. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Am Heart J 2007; 153: 941-50.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
6. Denes P, el-Sherif N, Katz R, Capone R, Carlson M, Mitchell LB, et al. Prognostic significance of signal-averaged electrocardiogram after thrombolytic therapy and/or angioplasty during acute myocardial infarction (CAST substudy). Cardiac Arrhythmia Suppression Trial (CAST) SAECG Substudy Investigators. Am J Cardiol 1994; 74: 216-20.
7. La Rovere MT, Bigger JT Jr, Marcus FL, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-84.
8. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, et al; Multicenter Automatic Defibrillator Implantation Trial II investigators. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2004; 44: 1481-7.
9. Berkowitsch A, Zareba W, Neumann T, Erdogan A, Nitt SM, Moss AJ, et al. Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute holter recording. Ann Noninvasive Electrocardiol 2004; 9: 270-9.
10. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 2004; 110: 1885-9.
11. Molnar J, Weiss JS, Rosenthal JE. Does heart rate identify sudden death survivors? Assessment of heart rate, QT interval, and heart rate variability. Am J Ther 2002; 9: 99-110.
12. Dougherty CM, Burr RL. Comparison of heart rate variability in survivors and nonsurvivors of sudden cardiac arrest. Am J Cardiol 1992; 70: 441-8.
13. Huikuri HV, Linnaluoto MK, Seppanen T, Airaksinen KE, Kessler KM, Takkunen JT, et al. Circadian rhythm of heart rate variability in survivors of cardiac arrest. Am J Cardiol 1992; 70: 610-5.
14. Lombardi F, Porta A, Marzegalli M, Favale S, Santini M, Vincenti A, et al; Implantable Cardioverter Defibrillator-Heart Rate Variability Italian Study Group. Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator. Participating Investigators of ICD-HRV Italian Study Group. Am J Cardiol 2000; 86: 959-63.
15. Pruvot E, Thonet G, Vesin JM, van-Melle G, Seidl K, Schmidinger H, et al. Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation 2000; 101: 2398-404.
16. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-62.
17. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164-71.
18. Zuanetti G, Neilson JM, Latini R, Santoro E, Maggioni AP, Ewing DJ. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation 1996; 94: 432-6.
19. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Makikallio TH, Airaksinen J, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003; 42: 652-8.
20. Stein PK, Domitrovich PP, Kleiger RE; CAST Investigators. Including patients with diabetes mellitus or coronary artery bypass grafting decreases the association between heart rate variability and mortality after myocardial infarction. Am Heart J 2004; 147: 309-16.
21. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481-8.
22. Bilchick KC, Bigger RD. Heart rate variability. J Cardiovasc Electrophysiol 2006; 17: 691-4.
23. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993; 88: 927-34.
24. Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 2000; 35: 1263-75.
25. Camm AJ, Pratt CM, Schwartz PJ, Al-Khalidi HR, Spyt MJ, Holroyde MJ, et al; AzimiLide post Infarct surVival Evaluation (ALIVE) Investigators. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 2004; 109: 990-6.
26. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure. Circulation 1998; 98: 1510-6.
27. Szabo BM, van Veldhuisen DJ, van der Veer N, Brouwer J, De Graeff PA, Crijns HJ. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1997; 79: 978-80.
28. Bilchik KC, Fetics B, Djoukeng R, Gross Fisher S, Fletcher RD, Singh SN, et al. Prognostic value fo heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial Of Antiarrhythmic Therapy In Congestive Heart Failure). Am J Cardiol 2002; 90: 24-8.
29. Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999; 33: 1203-7.
30. Galinier M, Pathak A, Fourcade J, Android C, Curnier D, Varnous S, et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 2000; 21: 475-82.
31. Guzzetti S, La Rovere MT, Pinna GD, Maestro R, Borroni E, Porta A, et al. Different spectral components of 24h heart rate variability are related to different modes of death in chronic heart failure. Eur Heart J 2005; 26: 357-62.
32. La Rovere MT, Pinna GD, Maestro R, Mortara A, Capomolla S, Febo O, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003; 107: 565-70.
33. Bigger JT Jr, Steinman RC, Rolnitzky LM, Fleiss JL, Albrecht P, Cohen RJ. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation. 1996; 93: 2142-51.
34. Makikallio TH, Hoiber S, Kober L, Torp-Pedersen C, Peng CK, Goldberger AL, et al. Fractal analysis of heart rate dynamics as a predictor of mortality in patients with depressed left ventricular function after acute myocardial infarction. TRACE Investigators. TRAndolapril Cardiac Evaluation. Am J Cardiol 1999; 83: 836-9.
35. Huikuri HV, Makikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000; 101: 47-53.
36. Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, et al. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 2005; 26: 762-9.
37. Makikallio TH, Huikuri HV, Hintze U, Videbæk J, Mitrani RD, Castellanos A, et al; for the DIAMOND Study Group. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 2001; 87: 178-82.
38. Brouwer J, van Veldhuisen DJ, Man in't Veld AJ, Haaksma J, Dijk WA, Visser KR, et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. J Am Coll Cardiol 1996; 28: 1183-9.
39. Wichterle D, Simek J, La Rovere MT, Schwartz PJ, Camm AJ, Malik M. Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction. Circulation 2004; 110: 1183-90.
40. Wichterle D, Simek J, Camm J, Malik M. Predictive characteristics of Holter-based postinfarction risk stratifiers appear superior to electrophysiological testing. Pacing Clin Electrophysiol 2005; 28: S182-6.
41. Kiviniemi AM, Tulppo MP, Wichterle D, Hautala AJ, Tiinanen S, Seppanen T, et al. Novel spectral indexes of heart rate variability as predictors of sudden and non-sudden cardiac death after an acute myocardial infarction. Ann Med 2007; 39: 54-62.